University of Oklahoma Health: Experimental Drug Offers Hope for Patients With Advanced Pancreatic Cancer
April 16, 2026
April 16, 2026
OKLAHOMA CITY, Oklahoma, April 16 -- The University of Oklahoma Health campus issued the following news:
* * *
Experimental Drug Offers Hope for Patients with Advanced Pancreatic Cancer
Results from a Phase 3 clinical trial offer new hope for patients with advanced pancreatic cancer, showing the experimental drug daraxonrasib significantly extended survival compared with chemotherapy alone. Researchers at the University of Oklahoma Health Stephenson Cancer . . .
* * *
Experimental Drug Offers Hope for Patients with Advanced Pancreatic Cancer
Results from a Phase 3 clinical trial offer new hope for patients with advanced pancreatic cancer, showing the experimental drug daraxonrasib significantly extended survival compared with chemotherapy alone. Researchers at the University of Oklahoma Health Stephenson Cancer . . .